Strategies for prevention of neonatal invasive candidiasis

Area of Science:

• Neonatal Medicine
• Infectious Diseases
• Pharmacology

Background:

• Fungal sepsis poses a significant threat to preterm infants, particularly those with low birth weight and multiple risk factors.
• Identifying effective preventative strategies is crucial to reduce the high mortality and morbidity associated with fungal infections in neonates.

Purpose of the Study:

• To evaluate the efficacy of intravenous fluconazole prophylaxis in preventing fungal sepsis in high-risk preterm infants.

Main Methods:

• A single-center, randomized, placebo-controlled trial was conducted.
• Participants included preterm infants weighing less than or equal to 1,000 grams with a central venous catheter or endotracheal tube.
• Prophylaxis was administered until intravenous access was no longer required or 6 weeks postnatal age was attained.

Main Results:

• Intravenous fluconazole prophylaxis was effective in preventing fungal sepsis in the studied preterm infant population.
• High-risk infants were defined by gestational age, specific medical interventions (antibiotics, H2 blockers, steroids, nutrition), and invasive procedures.

Conclusions:

• Intravenous fluconazole prophylaxis demonstrates efficacy in preventing fungal sepsis in high-risk preterm infants.
• Further research in larger populations is warranted to confirm these findings and explore other potential antifungal strategies.
• Effective prophylaxis can significantly decrease mortality and morbidity in high-risk neonates.